PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cancer's hiding spots revealed

Discovery that tumor cells can escape from chemotherapy could lead to new treatments that prevent relapse

2010-10-29
(Press-News.org) CAMBRIDGE, Mass. -- In a study of mice with lymphoma, MIT biologists have discovered that a small number of cancer cells escape chemotherapy by hiding out in the thymus, an organ where immune cells mature. Within the thymus, the cancer cells are bathed in growth factors that protect them from the drugs' effects. Those cells are likely the source of relapsed tumors, said Michael Hemann, MIT assistant professor of biology, who led the study.

The researchers plan to soon begin tests, in mice, of drugs that interfere with one of those protective factors. Those drugs were originally developed to treat arthritis, and are now in clinical trials for that use. Such a drug, used in combination with traditional chemotherapy, could offer a one-two punch that eliminates residual tumor cells and prevents cancer relapse, according to the researchers.

"Successful cancer therapy needs to involve a component that kills tumor cells as well as a component that blocks pro-survival signals," said Hemann, who is a member of MIT's David H. Koch Institute for Integrative Cancer Research. "Current cancer therapies fail to target this survival response."

Hemann and graduate student Luke Gilbert described the findings in the Oct. 29 issue of the journal Cell.

In the new study, the researchers treated mice with lymphoma with doxorubicin, a drug commonly used to treat a wide range of cancers, including blood cancers. They found that during treatment, cells that line the blood vessels release cytokines — small proteins that influence immune responses and cell development.

The exact mechanism is not known, but the researchers believe that chemotherapy-induced DNA damage provokes those blood-vessel cells to launch a stress response that is normally intended to protect progenitor cells — immature cells that can become different types of blood cells. That stress response includes the release of cytokines such as interleukin-6, which promotes cell survival.

"In response to environmental stress, the hardwired response is to protect privileged cells in that area, i.e., progenitor cells," said Hemann. "These pathways are being coopted by tumor cells, in response to the frontline cancer therapies that we use."

The discovery marks the first time scientists have seen a protective signal evoked by chemotherapy in the area surrounding the tumor, known as the tumor microenvironment. "It's completely unexpected that drugs would promote a survival response," said Hemann. "The impact of local survival factors is generally not considered when administering chemotherapy, let alone the idea that frontline chemotherapy would induce pro-survival signals."

It remains to be seen if the results will translate to human patients, but the finding does suggest several potential drug targets, including IL-6 and a protein called Bcl2, which is activated by IL-6 and signals cells to stay alive. While the MIT researchers observed this protective effect only in the thymus, they believe there may be other protected areas where tumor cells hide, such as the bone marrow.

This finding could help explain why tumors that have spread to other parts of the body before detection are more resistant to frontline chemotherapy: They may have already engaged a protective cytokine system, helping them to survive the drugs' effects.

Hemann hopes to further clarify the mechanism in future studies, in collaboration with Professor Michael Yaffe, also a member of the Koch Institute. He also plans to investigate whether this kind of pro-survival signal is elicited in other types of cancer, including tumors that have metastasized.

###

END



ELSE PRESS RELEASES FROM THIS DATE:

In response to chemo, healthy cells shield cancer cells

2010-10-29
Many times, cancer patients respond very well to chemotherapy initially only to have their disease return, sometimes years later. Now researchers reporting in the October 29th issue of the journal Cell, a Cell Press publication, have new insight into the factors that allow some lingering tumor cells to resist treatment and to seed that kind of resurgence. Contrary to expectations, it appears that the answer doesn't necessarily lie in the cancerous cells themselves. The evidence based on studies of mice with lymphoma shows that cues coming from healthy cells in response ...

Low birth weight may lead to poor growth rate in children with kidney disease

Low birth weight may lead to poor growth rate in children with kidney disease
2010-10-29
The lower the birth weight, the greater the chance of poor growth rate in children with chronic kidney disease (CKD), according to a new study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). In the general population, low birth weight is not an important cause of poor growth and short stature. To determine whether low birth weight is a risk factor for poor growth in children with CKD, Larry Greenbaum, MD, PhD (Emory University and Children's Healthcare of Atlanta, Atlanta, GA) and his colleagues analyzed results from ...

Caltech/JPL experiments improve accuracy of ozone predictions in air-quality models

Caltech/JPL experiments improve accuracy of ozone predictions in air-quality models
2010-10-29
PASADENA, Calif.—A team of scientists led by researchers from the California Institute of Technology (Caltech) and NASA's Jet Propulsion Laboratory (JPL) have fully characterized a key chemical reaction that affects the formation of pollutants in smoggy air. The findings suggest that in the most polluted parts of Los Angeles—and on the most polluted days in those areas—current models are underestimating ozone levels, by between 5 to 10 percent. The results—published in this week's issue of the journal Science—are likely to have "a small but significant impact on the predictions ...

Genetic variants may affect the risk of breast cancer in women with BRCA2 mutations

2010-10-29
NEW YORK, October 28, 2010 – An international study led by researchers at Memorial Sloan-Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer. The study was published today online in the open-access journal PLoS Genetics. The findings of the study suggest that genetic variants on chromosomes 10 and 20 may modify risk for breast cancer among women with a BRCA2 mutation. Researchers analyzed DNA samples from 6,272 women with BRCA2 mutations in a two-stage genome-wide ...

Protein preserves delicate balance between immune response and host

2010-10-29
White blood cells called neutrophils are part of the body's first line of defense against bacterial infection. Neutrophils are recruited from the bloodstream to infected tissues where they release powerful chemicals that kill bacteria and amplify the immune response. These cells function as first responders at the scene of infection and often have a short life span. As a result, new neutrophils are produced continuously from stem cells in the bone marrow. Previous research has suggested that regulation of neutrophil production is a complex and carefully controlled process. "We ...

Uncovering the cause of a common form of muscular dystrophy

2010-10-29
SEATTLE – An international team of researchers led by an investigator from Fred Hutchinson Cancer Research Center has made a second critical advance in determining the cause of a common form of muscular dystrophy known as facioscapulohumeral dystrophy, or FSHD. In August 2010 the group published a landmark study that established a new and unifying model for the cause of FSHD. The current work, published Oct. 28 in PLoS Genetics, shows that the disease is caused by the inefficient suppression of a gene that is normally expressed only in early development. The work will ...

Getting a grip on CO2 capture

Getting a grip on CO2 capture
2010-10-29
The ability to keep CO2 out of the atmosphere to help prevent climate change is a global issue. The challenge is to use materials that can capture the CO2 and easily release it for permanent storage. Researchers at the University of Calgary and University of Ottawa have provided deeper insights to CO2 capture by "seeing" the exact sites where CO2 is held in a capture material. Their discovery, published in prestigious journal Science, will allow scientists to design better materials to capture more CO2. The findings can be likened to learning about a better fit between ...

Olive oil protects liver

2010-10-29
Extra-virgin olive oil can protect the liver from oxidative stress. Researchers writing in BioMed Central's open access journal Nutrition and Metabolism exposed rats to a moderately toxic herbicide known to deplete antioxidants and cause oxidative stress, finding that those rats fed on a diet containing the olive oil were partially protected from the resulting liver damage. Mohamed Hammami from the University of Monastir, Tunisia and King Saud University, Riyadh, Saudi Arabia, worked with a team of researchers to carry out the experiments in a group of 80 rats. He said, ...

Not putting the clocks back this weekend will improve health, says expert

2010-10-29
Mayer Hillman, Senior Fellow Emeritus at the Policy Studies Institute, argues that the effect of doing so would be to increase the number of 'accessible' daylight hours and thus encourage more outdoor activity throughout the year. A major public health problem contributing to the incidence of chronic illnesses in the UK is caused by lack of exercise, writes Hillman. Adults are recommended to engage in at least 30 minutes of moderate or vigorous activity daily and children at least one hour. However, surveys have revealed a trend towards declining fitness and it has been ...

Study identifies 5 risk factors for late-stage head and neck cancer

Study identifies 5 risk factors for late-stage head and neck cancer
2010-10-29
DETROIT – Developing a molecular fingerprint for head and neck cancer tumors could help improve diagnosis and treatment for this deadly and often-times disfiguring form of cancer, according to researchers at Henry Ford Hospital in Detroit. Their new study has taken the first step toward doing that by identifying five risk factors for late-stage head and neck cancer – two genes, tumor grade, and vascular invasion and location of the tumor. Race, however, was not an independent predictor for late-stage disease, contrary to other research findings. In fact, 88 percent ...

LAST 30 PRESS RELEASES:

Premenstrual symptoms linked to increased risk of cardiovascular disease

Newly discovered remains of ancient river landscapes control ice flow in East Antarctica

Newly discovered interstellar object 'may be oldest comet ever seen'

Animal-inspired AI robot learns to navigate unfamiliar terrain

Underserved youth less likely to visit emergency department for concussion in Ontario, study finds

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

[Press-News.org] Cancer's hiding spots revealed
Discovery that tumor cells can escape from chemotherapy could lead to new treatments that prevent relapse